Real-world impact of nirsevimab immunisation and maternal RSV vaccination against respiratory disease on emergency department attendances and admissions: a multinational retrospective analysis
Authors
- Valtýr Thors (ORCID: https://orcid.org/0000-0002-0976-9604)
- Robin Marlow (ORCID: https://orcid.org/0000-0002-3192-3102)
- Paul G. Leonard (ORCID: https://orcid.org/0000-0003-2661-5532)
- Montserrat Martínez (ORCID: https://orcid.org/0009-0007-3390-8372)
- Antonio CHIARETTI
- Damian Roland
- Mihai Craiu
- Antoni Soriano-Arandes
- Clara Prats
- Aida Perramon-Malavez
- Jorgina Vila
- Thomas C. Williams
- Steve Foster
- Danilo Buonsenso
- Anna Creus-Costa
- Ermengol Coma
Institutions
- Università Cattolica del Sacro Cuore (IT)
- University of Leicester (GB)
- Carol Davila University of Medicine and Pharmacy (RO)
- Leicester Royal Infirmary (GB)
- Basque Government (ES)
- Royal Hospital for Children (GB)
- Government of Spain (ES)
- Bristol Royal Hospital for Children (GB)
- Agostino Gemelli University Polyclinic (IT)
- Vall d'Hebron Institut de Recerca (ES)
- National University Hospital of Iceland (IS)
- Institutul National pentru Sanatatea Mamei si Copilului "Alessandrescu-Rusescu" (RO)
- Vall d'Hebron Hospital Universitari (ES)
- Institut Català de la Salut (ES)
- Hospital de Palamós (ES)
- Reykjavík Energy (Iceland) (IS)
- Universitat Politècnica de Catalunya (ES)
- University of Edinburgh (GB)
Publication Details
- Journal
- The Lancet Regional Health - Europe
- Published
- 2026-02-03
- DOI
- https://doi.org/10.1016/j.lanepe.2026.101597
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00